Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Comparison of Omicron and Delta Variants of Sars-Cov-2: A Systematic Review of Current Evidence Publisher Pubmed



Seyedalinaghi S1 ; Afsahi AM2 ; Mirzapour P1 ; Afzalian A3 ; Shahidi R4 ; Dashti M5 ; Ghasemzadeh A5 ; Paranjkhoo P6 ; Parsaei Z7 ; Pashaei A8 ; Mohammadi P9 ; Najafi MS10 ; Mahrokhi S1 ; Matini P9 Show All Authors
Authors
  1. Seyedalinaghi S1
  2. Afsahi AM2
  3. Mirzapour P1
  4. Afzalian A3
  5. Shahidi R4
  6. Dashti M5
  7. Ghasemzadeh A5
  8. Paranjkhoo P6
  9. Parsaei Z7
  10. Pashaei A8
  11. Mohammadi P9
  12. Najafi MS10
  13. Mahrokhi S1
  14. Matini P9
  15. Moradi A9
  16. Karimi A9
  17. Afroughi S11
  18. Mehraeen E12
  19. Dadras O13

Source: Infectious Disorders - Drug Targets Published:2024


Abstract

Introduction: Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) caused the outbreak of coronavirus disease 2019 (COVID-19) in late 2019 in Wuhan, China. In early 2020, the disease spread rapidly around the world. Since the pandemic, SARS-CoV-2 has evolved dramatically into a wide variety of variants endowed with devastating properties. As of March 6, 2022, five SARS-CoV-2 variants of concern, including Alpha, Beta, Gamma, Delta, and Omicron strains have been identified. Due to the crucial importance of understanding the differences between the Omicron and Delta variants, this systematic review was conducted. Methods: This systematic review investigated new variants of Omicron SARS-CoV-2 based on current studies. Online databases were searched for English articles as of January 03, 2023. Selection of publications was a two-step process of title/abstract and full-text assessment against eligibility criteria. The relevant data from the included articles were systematically collected and organized in a designed table for analysis. To ensure the quality of the review, the PRISMA checklist and Newcastle-Ottawa Scale (NOS) of quality assessment were utilized. Results: The data extracted from 58 articles were analyzed, including 10003 pieces of evidence. Lower risk of hospitalization, ICU admission, and mortality after vaccination were reported in the Omicron variant compared to the Delta variant. Additionally, the Delta variant led to more severe clinical symptoms in comparison to the Omicron variant. Conclusion: The Omicron variant of SARS-CoV-2 results in less severe disease outcomes as compared to Delta. Nevertheless, it remains crucial to maintain ongoing monitoring, implement containment measures, and adapt vaccination protocols to effectively address the evolving variants. © 2024 Bentham Science.
Related Docs
View other Related Docs
1. Comparison of Clinical Outcomes, Demographic, and Laboratory Characteristics of Hospitalized Covid-19 Patients During Major Three Waves Driven by Alpha, Delta, and Omicron Variants in Tehran, Iran, Influenza and other Respiratory Viruses (2023)
2. New Variants of Covid-19 (Xbb.1.5 and Xbb.1.16, the “Arcturus”): A Review of Highly Questioned Concerns, a Brief Comparison Between Different Peaks in the Covid-19 Pandemic, With a Focused Systematic Review on Expert Recommendations for Prevention, Vaccination, and Treatment Measures in the General Population and At-Risk Groups, Immunity, Inflammation and Disease (2024)
3. An Overview on the Genomic Characteristics of the New Coronavirus (2019-Ncov) and the Prospective in Pathogenesis and Treatment of Covid-19 Infection, Journal of Isfahan Medical School (2020)
Experts (# of related papers)
View all Related Experts
Seyed Hossein Mirhendi Esfahani (2)
Shaghayegh Haghjooy Javanmard (2)
Other Related Docs
4. A Review of Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2), Iranian Journal of Medical Microbiology (2020)
5. Emerging Coronaviruses: First Sars, Second Mers and Third Sars-Cov-2. Epidemiological Updates of Covid-19, Infezioni in Medicina (2020)
6. Sars-Cov-2 Antibody Seroprevalence in the General Population and High-Risk Occupational Groups Across 18 Cities in Iran: A Population-Based Cross-Sectional Study, The Lancet Infectious Diseases (2021)
7. Study of the Possible Origin and Evolution of Coronaviruses, Focusing on Recent 2019 Novel Coronavirus (Covid-19), Journal of Isfahan Medical School (2021)
8. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
9. Potential Treatments for Covid-19; a Narrative Literature Review, Archives of Academic Emergency Medicine (2020)
10. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
11. Investigating Methods for Coronavirus Disease 2019 Control: A Systematic Review, Polish Annals of Medicine (2021)
12. Sars-Cov-2, Sars and Mers: Three Formidable Coronaviruses Which Have Originated From Bats; [Sars-Cov-2, Sars-Cov I Mers-Cov: Trzy Grozne Koronawirusy Pochodzace Od Nietoperzy], Postepy Higieny i Medycyny Doswiadczalnej (2021)
13. Nervous System Involvement in Covid-19: A Review of the Current Knowledge, Molecular Neurobiology (2021)
14. Effectiveness of Corticosteroid Therapy in Patients With Moderate to Severe Coronavirus Disease 2019: A Retrospective Study, Journal of Nephropharmacology (2023)
15. Environmental Aspects of the Coronaviruses Transmission: A Narrative Review, Journal of Isfahan Medical School (2020)
16. An Updated Review of the Association of Host Genetic Factors With Susceptibility and Resistance to Covid-19, Journal of Cellular Physiology (2021)
17. Covid-19 Pandemic: Insights Into Genetic Susceptibility to Sars-Cov-2 and Host Genes Implications on Virus Spread, Disease Severity and Outcomes, Human Antibodies (2022)
18. Classification of Viral Proteins Expressed by the Sars-Cov-2 Genome, Acta Microbiologica Hellenica (2022)
19. A Mini-Review on Cardiovascular and Hematological Complications of Covid-19, Coronaviruses (2021)
20. Co-Infection Between the Severe Acute Respiratory Syndrome Coronavirus 2 and the Influenza Type B in Isfahan, Iran, Journal of Research in Medical Sciences (2021)